These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 25061854

  • 1. What's new in the topical treatment of allergic skin diseases.
    Aslam I, Sandoval LF, Feldman SR.
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):436-50. PubMed ID: 25061854
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A clinician's paradigm in the treatment of atopic dermatitis.
    Abramovits W.
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S70-7. PubMed ID: 15968266
    [Abstract] [Full Text] [Related]

  • 8. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
    Broeders JA, Ahmed Ali U, Fischer G.
    J Am Acad Dermatol; 2016 Aug; 75(2):410-419.e3. PubMed ID: 27177441
    [Abstract] [Full Text] [Related]

  • 9. Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm.
    Luger T, De Raeve L, Gelmetti C, Kakourou T, Katsarou A, Lambert J, Morren MA, Oranje A, Ruer M, Serdaroglu S, Torrelo A, Werfel T.
    Eur J Dermatol; 2013 Aug; 23(6):758-66. PubMed ID: 24185493
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis.
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Not Available].
    Darrigade AS.
    Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S85-12S95. PubMed ID: 31997737
    [Abstract] [Full Text] [Related]

  • 14. Emerging drugs for atopic dermatitis.
    Ong PY.
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):165-79. PubMed ID: 19216704
    [Abstract] [Full Text] [Related]

  • 15. Three randomised phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis.
    Peltonen JM, Pylkkänen L, Jansén CT, Volanen I, Lehtinen T, Laihia JK, Leino L.
    Acta Derm Venereol; 2014 Jul; 94(4):415-20. PubMed ID: 24284985
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH.
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [Abstract] [Full Text] [Related]

  • 19. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
    Hong CH, Gooderham M, Bissonnette R.
    J Cutan Med Surg; 2019 May; 23(4_suppl):5S-10S. PubMed ID: 31476937
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Eczema: Corticosteroids and Beyond.
    Chong M, Fonacier L.
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):249-262. PubMed ID: 25869743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.